Inquiry Basket
3,6,9,12-Tetraoxapentadec-14-yn-1-ol | 87450-10-0
| Catelog Number | R01-0191 |
| Category | Alkynes |
| Molecular Formula | C₁₁H₂₀O₅ |
| Molecular Weight | 232.27 |
| Catalog Number | Size | Price | Quantity |
|---|---|---|---|
| R01-0191 | -- | $-- |
- Worldwide Delivery
- Quality Assurance
- 24/7 Customer Service
Product Introduction
3,6,9,12-Tetraoxapentadec-14-yn-1-ol is a polyethylene glycol (PEG)-based PROTAC linker that can be used in the synthesis of a series of PROTACs.
Chemical Information |
|
|---|---|
| Related CAS | 32199-97-6 (polymer) |
| Synonyms | Propargyl-PEG5-alcohol; HC≡C-CH2-PEG4-OH; Propyne-PEG4-OH; Propargyl-PEG4-OH; 3,6,9,12-Tetraoxa-14-pentadecyne-1-ol; 15-hydroxy-4,7,10,13-tetraoxapentadec-1-yne |
| Purity | >97% |
| IUPAC Name | 2-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethoxy]ethanol |
| Canonical SMILES | C#CCOCCOCCOCCOCCO |
| InChI | InChI=1S/C11H20O5/c1-2-4-13-6-8-15-10-11-16-9-7-14-5-3-12/h1,12H,3-11H2 |
| InChI Key | WQMJFCWQBPUZCK-UHFFFAOYSA-N |
| Solubility | Soluble in DMSO |
| Density | 1.071±0.06 g/cm3 (Predicted) |
| Appearance | Colorless or Light Yellowish Liquid |
| Boiling Point | 324.4±32.0 °C at 760 mmHg |
Product Specification |
|
|---|---|
| Storage | Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years) |
| Signal | Warning |
| GHS Hazard Statements | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
| Precautionary Statement Codes | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (The corresponding statement to each P-code can be found at the GHS Classification page.) |
Computed Properties | |
|---|---|
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 12 |
| Exact Mass | 232.13107373 g/mol |
| Monoisotopic Mass | 232.13107373 g/mol |
| Topological Polar Surface Area | 57.2Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 175 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2022190915-A1 | Novel compound or salt thereof, and antitumor activator containing same as active ingredient | 2021-03-10 |
| WO-2022150726-A1 | Hypoimmunogenic biotherapeutics | 2021-01-11 |
| WO-2021018018-A1 | Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inidbitors with e3 ligase ligand and methods of use | 2019-07-26 |
| US-2022281876-A1 | Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use | 2019-07-26 |
| WO-2021011913-A1 | Tau-protein targeting compounds and associated methods of use | 2019-07-17 |
Applications of Fluorescent Probes & Dyes
Get More Product Details?
Related Products
